Format

Send to

Choose Destination
Thorac Cardiovasc Surg. 2004 Aug;52(4):206-10.

Outcome of surgery for small cell lung cancer -- response to induction chemotherapy predicts survival.

Author information

1
Department of Respiratory Surgery, International University of Health and Welfare Atami Hospital, Shizuoka, Japan. h.nakamura@iuhw.ac.jp

Abstract

BACKGROUND:

The role of surgery for local control of small cell lung cancer (SCLC) is controversial.

METHODS:

Sixty-nine consecutive patients who underwent complete resection of SCLC in our hospital were reviewed. The patients included 62 men and 7 women. Clinical stage at the time of diagnosis was c-stages IA and B in 29, c-stages IIA and B in 12, c-stage IIIA in 21, and c-stage IIIB in 7.

RESULTS:

Thirty-two patients received induction chemotherapy, and 37 patients underwent initial surgery. The overall response rate to induction chemotherapy was 71.9 %. The survival rate stratified by clinical stage at the time of diagnosis was 48.9 % for c-stage I, 33.3 % for c-stage II, 20.2 % for c-stage IIIA, and 0 % for c-stage IIIB. Downstaging after induction chemotherapy conferred a survival benefit. Survival after lobectomy or bilobectomy was better than after pneumonectomy. Patients who received adjuvant chemotherapy survived longer than patients who did not.

CONCLUSIONS:

Surgery combined with chemotherapy is a therapeutic option in selected patients with SCLC. Pathologic nodal status and response to induction chemotherapy are predictors of survival.

PMID:
15293157
DOI:
10.1055/s-2004-821075
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Georg Thieme Verlag Stuttgart, New York
Loading ...
Support Center